Navigation Links
Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
Date:3/20/2008

GAITHERSBURG, Md., March 20 /PRNewswire/ -- Lentigen Corporation today announced an exclusive licensing agreement with Case Western Reserve University (CWRU) in Cleveland, Ohio, to develop a novel stem-cell therapy for glioblastoma, an aggressive type of brain cancer. Under the agreement, Case Western and its primary affiliate, University Hospitals Case Medical Center, will lead the first in vivo clinical trial, and Lentigen will be responsible for further clinical development and commercialization.

The new therapy will be based on MGMT, a gene that has been shown to repair damaged DNA. A specially designed lentiviral vector will be used to deliver the gene specifically to bone-marrow stem cells that have been damaged by drugs commonly used to treat cancer. A Phase I clinical trial, which will be held at Case Western later this year, will evaluate the potential of this lentiviral vector-MGMT technology (LV-MGMT) to enhance current treatments for glioblastoma by repairing and preventing this damage to bone-marrow stem cells.

"This clinical trial will represent the first time lentiviral vectors will be used with MGMT for stem cell therapy in humans," said Stanton L. Gerson, MD, director of the Ireland Cancer Center of University Hospitals Case Medical Center and the Case Comprehensive Cancer Center, who co-developed the technology with Anthony E. Pegg, Ph.D., the Evan Pugh Professor of Cellular and Molecular Physiology, and Pharmacology at Penn State University. Dr. Gerson commented, "Glioblastoma is a serious diagnosis with limited treatment options, so this new therapeutic approach has the potential to greatly enhance options for patients with this terrible disease."

Boro Dropulic, Ph.D., Lentigen's founder, president and chief scientific officer, commented, "LV-MGMT technology has the potential to greatly enhance the therapeutic efficacy of existing drugs that target glioblastoma by lowering their toxicity to bone marrow stem cells. Beyo
'/>"/>

SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. VIRxSYS and Lentigen Announce Litigation Settlement
2. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
3. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 ... a painful year. Not so for BodyLogicMD. The nati... physicians specializing exclusively in medically ...number of physicians in its network since No...n progress to add more physician-owned centers, in...
(Date:11/24/2009)...e is available in German . , Whether it,s C...FID tags (Radio Frequency Identification) are incr...y make it possible to label objects or goods and i... appropriate scanner can read and process the data...ed to goods under production conditions of up to 1...
(Date:11/24/2009)...LGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire-F...ay it is acquiring the assets of Hyland Seeds, a d... The addition of Hyland Seeds will further expand ...mpany anticipates the introduction of SmartStax(T...erant Trait Technology in corn in 2012. The transa...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Ph...rademark Office (PTO) has allowed the patent appli...technology. , NOD technology is a highly ...eins into bio-adhesive nano-particles to enable or...ections. NOD technology is a platform technology,t...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... of the,Sigma-Aldrich(TM) Group (Nasdaq: SIAL ), ... new cGMP potent active pharmaceutical ingredients...t. Louis manufacturing campus.,This addition is ex...ents,that demand a combination of small molecule c...d biologics manufacturing and extensive Quality,Co...
...e-toothed cat Smilodon ranks alongside Tyrannosaur... built, with upper canines like knives, Smilodon w...iants. , For more than 150 years, scientists hav...ous fangs to kill its prey. Now a new Australian s... National Academy of Science, hopes to lay the arg...
...ific,Corporation (NYSE: BSX ) will webcast its co... third quarter ended September 30, 2007 on Friday,...ted by Jim Tobin, President and Chief Executive,Of...nd Sam Leno, Executive,Vice President and Chief Fi...play of this call will be available at, http://www...
Other Biology Technology:SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite 2SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite 3Scientists say sabercat bit like a pussycat 2Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 2
(Date:11/24/2009)...rystallised a protein that may help gut bacteria b...ld be used by probiotic producers to identify stra...e. , "Probiotics need to interact with cells lini...y attach to surfaces in the gut they are more like...vity," says Dr Nathalie Juge from the Institute of...
(Date:11/24/2009)...tarctica has long held secrets of the earth,s hist...there has been very little information on the envi...e for millions of years. Now, a team of researcher... funded to the tune of $10 million dollars by the ... bottom of things literally. These scientists wil...
(Date:11/23/2009)... The community-associated strain of the deadly sup...to most common antibioticsposes a far greater heal...way into hospitals, according to a study in the De..., The new threat is easily picked up in fitness c...ncreased the overall burden of MRSA within hospita...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 1CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 2CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 3CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 4Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 1Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 2Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 3Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 1Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 2Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 3
...onas vaginalis colonises the urogenital tract and ...st common non-viral STI. , University of Queenslan...5 scientists that worked on the project to sequenc...eatments for both men and women. , Ms Dunne sai...n genes and gene families of interest, particularl...
...dies in the January 18, 2007, issue of the journal... light on how the brain processes numerical inform... representations as symbols. The researches said t... the brain processes quantitative information as w...tion in the brain develops in children. Such studi...
...rt C. von Borstel, cancer is a metaphorical exampl...ke the first pregnant finch that landed on a deser... cancer cell in the human body has to undergo many...tself as an invader of different organs in the bod... species in different ecological niches, cancer is...
Other Biology News:Scientists perform 'tricky' operation 2Studies yield insight into the numerical brain 2Studies yield insight into the numerical brain 3Studies yield insight into the numerical brain 4New bird, bat species revealed by extensive DNA barcode studies 2
BD BaculoGoldTM Transfection Kit 5 transfections from BD Biosciences Pharmingen
...lant Leaf DNA Purification Kit is designed for iso...ue. The protocol can be completed in less than one...s of DNA. The purified DNA can be used for PCR amp...otting. The MasterPure Kit was designed for even t...
Propidium iodide from Research Organics, Inc.
Sf9 Insect Cells from BD Biosciences Pharmingen
Biology Products: